IN8bio, Inc. (INAB) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by IN8bio, Inc., a Delaware corporation, with a report date of June 24, 2025. The filing addresses a specific regulatory event regarding the company's listing status on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a listing compliance event and does not contain financial performance data.
Material Changes
The material change reported is the resolution of a listing deficiency. On June 24, 2025, the Company received formal notification from Nasdaq confirming it has regained compliance with Nasdaq Listing Rule 5550(a)(2). This rule requires listed companies to maintain a minimum bid price of at least $1.00 per share. The matter is now closed.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, or outlook. The primary risk addressed was the potential delisting due to failure to meet the minimum bid price requirement, which has been resolved as of the report date.
Investor Verification Checklist
- Verify the current trading price of INAB to ensure it remains above the $1.00 minimum bid price threshold.
- Confirm the official status of the Nasdaq compliance matter on the Nasdaq Stock Market website.
- Review the company's most recent 10-Q or 10-K for financial metrics not included in this 8-K.